+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition



Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition



Molecular Pharmacology 77(2): 159-170



N-formyl peptide receptor (FPR1) and N-formyl peptide receptor-like 1 (FPRL1, now known as FPR2) are G protein-coupled receptors involved in host defense and sensing cellular dysfunction. Because of the potential for FPR1/FPR2 as a therapeutic target, our recent high-throughput screening efforts have focused on the identification of unique nonpeptide agonists of FPR1/FPR2. In the present studies, we screened a chemolibrary of drug-like molecules for their ability to induce intracellular calcium mobilization in RBL-2H3 cells transfected with human FPR1 or FPR2. Screening of these compounds resulted in the identification of novel and potent agonists that activated both FPR1 and FPR2, as well as compounds that were specific for either FPR1 or FPR2 with EC(50) values in the low micromolar range. Specificity of the compounds was supported by analysis of calcium mobilization in HL-60 cells transfected with human FPR1 and FPR2. In addition, all but one agonist activated intracellular calcium flux and chemotaxis in human neutrophils, irrespective of agonist specificity for FPR1 or FPR2. Molecular modeling of the group of FPR1 and FPR2 agonists using field point methodology allowed us to create pharmacophore models for ligand binding sites and formulate requirements for these specific N-formyl peptide receptor agonists. These studies further demonstrate that agonists of FPR1/FPR2 include compounds with wide chemical diversity and that analysis of such compounds can enhance our understanding of their ligand/receptor interaction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053669051

Download citation: RISBibTeXText

PMID: 19903830

DOI: 10.1124/mol.109.060673


Related references

Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors. European Journal of Medicinal Chemistry 45(11): 5406-5419, 2011

6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. Journal of Medicinal Chemistry 52(16): 5044-5057, 2010

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists. Molecular Pharmacology 71(4): 1061-1074, 2007

Molecular docking of 2-benzimidazol-2-ylthio-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor. 2011

Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1. Journal of Molecular Modeling 18(6): 2831-2843, 2012

Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. Current Medicinal Chemistry 21(13): 1478-1504, 2015

Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models. Chemical Biology & Drug Design 67(5): 318-328, 2006

Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors. Molecular Pharmacology 79(1): 77-90, 2011

Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site. European Journal of Immunology 24(1): 211-215, 1994

Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. Journal of Medicinal Chemistry 49(23): 6652-6655, 2006

Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. Journal of Immunology 163(12): 6777-6784, 1999

Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors. Journal of Pharmacology and Experimental Therapeutics 303(2): 445-460, 2002

2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. Bioorganic & Medicinal Chemistry (): -, 2016

Human neutrophil FccRIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Journal of Immunology 149: 9-97, 1992

Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation. Plos One 11(4): E0154229-E0154229, 2016